Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis

被引:53
作者
Lwin, T. [1 ,2 ]
Crespo, L. A. [1 ,2 ]
Wu, A. [1 ,2 ]
Dessureault, S. [1 ,2 ]
Shu, H. B.
Moscinski, L. C. [1 ,2 ]
Sotomayor, E. [1 ,2 ]
Dalton, W. S. [1 ,2 ]
Tao, J. [1 ,2 ]
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Oncol Sci, Tampa, FL 33613 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Expt Therapeut Program, Tampa, FL 33613 USA
关键词
non-Hodgkin's lymphoma; drug resistance; adhesion; BAFF; bone marrow stroma; NF-KAPPA-B; MYELOMA CELLS; AUTOIMMUNE-DISEASE; MULTIPLE-MYELOMA; DRUG-RESISTANCE; BAFF-R; RECEPTOR; APRIL; BLYS; BCMA;
D O I
10.1038/leu.2008.266
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study explores whether lymphoma cell adhesion-induced B cell-activating factor (BAFF) expression in bone marrow stromal cells (BMSCs) protects B lymphoma cells from apoptosis. We first showed protection of lymphoma cells from apoptosis by conditioned medium of a stromal cell-lymphoma cell coculture, either spontaneous or induced by mitoxantrone, implying a role for soluble factor(s) in lymphoma cell survival. Addition of BAFF counteracted mitoxantrone-induced apoptosis and elicited a reduction in spontaneous apoptosis in primary lymphomas, suggesting a role of BAFF in sustaining B-cell survival. Abundant BAFF was detected in the BMSC cell line (HS-5) and primary BMSCs by flow cytometry, RT-PCR and immunoblotting. BAFF levels were 20- to 200-fold higher in BMSCs than in lymphoma cells, and lymphoma cell adhesion to BMSCs augmented BAFF secretion twofold through upregulation of BAFF gene expression. Finally, neutralization of BAFF by TACI-Ig or depletion of BAFF by small hairpin RNA (shRNA) in BMSCs significantly enhanced lymphoma cell response to chemotherapy and overcame stroma-mediated drug resistance, suggesting that lymphoma cells use BMSC-derived BAFF as a survival factor. These findings support the hypothesis that lymphoma cells interact with BMSCs, resulting in stromal niches with high BAFF concentration, and identify BMSC-derived BAFF as a functional determinant for B lymphoma cell survival in the bone marrow environment.
引用
收藏
页码:170 / 177
页数:8
相关论文
共 27 条
[1]   BLyS* and BLyS receptor expression in non-Hodgkin's lymphoma [J].
Briones, J ;
Timmerman, JM ;
Hilbert, DM ;
Levy, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (02) :135-141
[2]   Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response [J].
Do, RKG ;
Hatada, E ;
Lee, H ;
Tourigny, MR ;
Hilbert, D ;
Chen-Kiang, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :953-964
[3]   B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia [J].
Elsawa, SF ;
Novak, AJ ;
Grote, DM ;
Ziesmer, SC ;
Witzig, TE ;
Kyle, RA ;
Dillon, SR ;
Harder, B ;
Gross, JA ;
Ansell, SM .
BLOOD, 2006, 107 (07) :2882-2888
[4]   Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas [J].
Fu, Lingchen ;
Lin-Lee, Yen-Chiu ;
Pham, Lan V. ;
Tamayo, Archito ;
Yoshimura, Linda ;
Ford, Richard J. .
BLOOD, 2006, 107 (11) :4540-4548
[5]   TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease [J].
Gross, JA ;
Johnston, J ;
Mudri, S ;
Enselman, R ;
Dillon, SR ;
Madden, K ;
Xu, WF ;
Parrish-Novak, J ;
Foster, D ;
Lofton-Day, C ;
Moore, M ;
Littau, A ;
Grossman, A ;
Haugen, H ;
Foley, K ;
Blumberg, H ;
Harrison, K ;
Kindsvogel, W ;
Clegg, CH .
NATURE, 2000, 404 (6781) :995-999
[6]   Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis [J].
Grumont, RJ ;
Rourke, IJ ;
Gerondakis, S .
GENES & DEVELOPMENT, 1999, 13 (04) :400-411
[7]  
Jelinek Diane E., 2005, V8, P266
[8]   Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway [J].
Kern, C ;
Cornuel, JF ;
Billard, C ;
Tang, RP ;
Rouillard, D ;
Stenou, V ;
Defrance, T ;
Ajchenbaum-Cymbalista, F ;
Simonin, PY ;
Feldblum, S ;
Kolb, JP .
BLOOD, 2004, 103 (02) :679-688
[9]   Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice [J].
Khare, SD ;
Sarosi, I ;
Xia, XZ ;
McCabe, S ;
Miner, K ;
Solovyev, I ;
Hawkins, N ;
Kelley, M ;
Chang, D ;
Van, G ;
Ross, L ;
Delaney, J ;
Wang, L ;
Lacey, D ;
Boyle, WJ ;
Hsu, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3370-3375
[10]   THE NF-KAPPA-B P50 PRECURSOR, P105, CONTAINS AN INTERNAL I-KAPPA-B-LIKE INHIBITOR THAT PREFERENTIALLY INHIBITS P50 [J].
LIOU, HC ;
NOLAN, GP ;
GHOSH, S ;
FUJITA, T ;
BALTIMORE, D .
EMBO JOURNAL, 1992, 11 (08) :3003-3009